CITIGROUP INC - ADAPTIMMUNE THERAPEUTICS PLC ownership

ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 49 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
CITIGROUP INC ownership history of ADAPTIMMUNE THERAPEUTICS PLC
ValueSharesWeighting
Q3 2023$454,175
-15.7%
582,275
+0.0%
0.00%
Q2 2023$538,531
+29752.1%
582,196
+35078.0%
0.00%
Q1 2023$1,804
-37.0%
1,655
-15.6%
0.00%
Q4 2022$2,865
-59.1%
1,962
-70.5%
0.00%
Q3 2022$7,000
-86.8%
6,649
-78.8%
0.00%
Q2 2022$53,000
+20.5%
31,431
+45.9%
0.00%
Q1 2022$44,000
-61.1%
21,537
-28.3%
0.00%
Q4 2021$113,000
-47.9%
30,049
-28.4%
0.00%
Q3 2021$217,000
+1.9%
41,991
-15.9%
0.00%
Q2 2021$213,000
-53.4%
49,923
-42.0%
0.00%
Q1 2021$457,000
+75.1%
86,001
+77.3%
0.00%
Q4 2020$261,000
+3162.5%
48,503
+4467.1%
0.00%
Q3 2020$8,000
-20.0%
1,062
+6.9%
0.00%
Q2 2020$10,000
+66.7%
993
-54.5%
0.00%
Q1 2020$6,0002,182
+10810.0%
0.00%
Q4 2019$0
-100.0%
20
-99.1%
0.00%
Q3 2019$3,000
-66.7%
2,184
+1.6%
0.00%
Q2 2019$9,000
+80.0%
2,149
+89.3%
0.00%
Q1 2019$5,000
-94.0%
1,135
-81.6%
0.00%
Q3 2018$84,000
+15.1%
6,1750.0%0.00%
Q2 2018$73,000
+2333.3%
6,175
+2089.7%
0.00%
Q1 2018$3,000
-75.0%
282
-84.7%
0.00%
Q4 2017$12,0001,846
+184500.0%
0.00%
Q1 2016$0
-100.0%
1
-100.0%
0.00%
Q3 2015$62,0005,2110.00%
Other shareholders
ADAPTIMMUNE THERAPEUTICS PLC shareholders Q4 2015
NameSharesValueWeighting ↓
Syncona Portfolio Ltd 1,377,294$2,341,0003.33%
Matrix Capital Management Company, LP 38,974,185$66,256,0001.50%
NEA Management Company, LLC 17,082,612$29,040,0001.49%
Endurant Capital Management LP 1,824,065$3,101,0001.09%
Long Focus Capital Management, LLC 4,679,491$7,955,0000.83%
Key Client Fiduciary Advisors, LLC 416,166$707,0000.69%
PFM Health Sciences, LP 9,109,780$15,487,0000.59%
ACT CAPITAL MANAGEMENT, LLC 90,000$153,0000.21%
DAFNA Capital Management LLC 351,064$597,0000.16%
Rock Springs Capital Management LP 2,357,544$4,008,0000.12%
View complete list of ADAPTIMMUNE THERAPEUTICS PLC shareholders